Kaufman Michael J. 4
4 · Mersana Therapeutics, Inc. · Filed Jul 19, 2019
Insider Transaction Report
Form 4
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
- Award
Restricted Stock Units
2019-07-17+40,000→ 40,000 total→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F2]The restricted stock units vest fully on July 15, 2021.